Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium

PURPOSE: To validate the safety and effectiveness of transarterial chemoembolization (TACE) combination with lenvatinib and sintilimab in treating hepatocellular carcinoma (HCC) patients with inferior vena cava (IVC) and/or right atrium (RA) tumor thrombosis (TT). METHODS: This study retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Shangkun, Li, Xinge, Ma, Xiangyu, Liu, Jibing, Chang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505388/
https://www.ncbi.nlm.nih.gov/pubmed/37724186
http://dx.doi.org/10.2147/JHC.S410967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505388/
https://www.ncbi.nlm.nih.gov/pubmed/37724186
http://dx.doi.org/10.2147/JHC.S410967

Ejemplares similares